KIEV, March 14 – The Ukrainian pharmaceutical market in the near future will face a large-scale reorganization after Ukraine joins the World Trade Organization, according to analysts of investment companies polled by Interfax-Ukraine.

"A fall in the prices of pharmaceutical products due to an increase in imports would affect most domestic producers, which in the medium and long-term outlook would have to leave the market or accept proposals of consolidation," said Stanyslav Kartavykh, senior analyst at Kiev-based Foyl Securities.